vs
Axon Enterprise（AXON）与Natera, Inc.（NTRA）财务数据对比。点击上方公司名可切换其他公司
Axon Enterprise的季度营收约是Natera, Inc.的1.2倍（$796.7M vs $665.5M），Natera, Inc.净利率更高（7.1% vs 0.3%，领先6.8%），Natera, Inc.同比增速更快（39.8% vs 38.9%），Axon Enterprise自由现金流更多（$155.4M vs $37.8M），过去两年Natera, Inc.的营收复合增速更高（34.5% vs 31.5%）
Axon Enterprise是总部位于美国亚利桑那州斯科茨代尔的企业，面向军队、执法部门及民用市场开发各类武器装备与相关技术产品，业务覆盖公共安全、国防及民用消费等多个领域，为不同用户群体提供适配的产品解决方案。
Natera是总部位于美国得克萨斯州奥斯汀的临床基因检测企业，主打无创游离DNA（cfDNA）检测技术，业务覆盖女性健康、肿瘤及器官健康三大核心赛道。其自研专利技术结合前沿分子生物学手段与生物信息学工具矩阵，可实现单管血液样本中低至单个分子级别的高灵敏度检测。
AXON vs NTRA — 直观对比
营收规模更大
AXON
是对方的1.2倍
$665.5M
营收增速更快
NTRA
高出0.8%
38.9%
净利率更高
NTRA
高出6.8%
0.3%
自由现金流更多
AXON
多$117.6M
$37.8M
两年增速更快
NTRA
近两年复合增速
31.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $796.7M | $665.5M |
| 净利润 | $2.7M | $47.3M |
| 毛利率 | 57.9% | — |
| 营业利润率 | -6.3% | -3.4% |
| 净利率 | 0.3% | 7.1% |
| 营收同比 | 38.9% | 39.8% |
| 净利润同比 | -98.0% | 187.9% |
| 每股收益（稀释后） | $0.02 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXONNTRA
| Q4 25 | $796.7M | $665.5M | ||
| Q3 25 | $710.6M | $592.2M | ||
| Q2 25 | $668.5M | $546.6M | ||
| Q1 25 | $603.6M | $501.8M | ||
| Q4 24 | $573.4M | $476.1M | ||
| Q3 24 | $544.3M | $439.8M | ||
| Q2 24 | $504.1M | $413.4M | ||
| Q1 24 | $460.7M | $367.7M |
净利润AXONNTRA
| Q4 25 | $2.7M | $47.3M | ||
| Q3 25 | $-2.2M | $-87.5M | ||
| Q2 25 | $36.1M | $-100.9M | ||
| Q1 25 | $88.0M | $-66.9M | ||
| Q4 24 | $136.0M | $-53.8M | ||
| Q3 24 | $67.0M | $-31.6M | ||
| Q2 24 | $40.8M | $-37.5M | ||
| Q1 24 | $133.2M | $-67.6M |
毛利率AXONNTRA
| Q4 25 | 57.9% | — | ||
| Q3 25 | 60.1% | — | ||
| Q2 25 | 60.4% | — | ||
| Q1 25 | 60.6% | — | ||
| Q4 24 | 60.5% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 60.3% | — | ||
| Q1 24 | 56.4% | — |
营业利润率AXONNTRA
| Q4 25 | -6.3% | -3.4% | ||
| Q3 25 | -0.3% | -16.5% | ||
| Q2 25 | -0.2% | -20.2% | ||
| Q1 25 | -1.5% | -15.8% | ||
| Q4 24 | -2.6% | -13.6% | ||
| Q3 24 | 4.4% | -8.9% | ||
| Q2 24 | 6.5% | -10.6% | ||
| Q1 24 | 3.5% | -20.2% |
净利率AXONNTRA
| Q4 25 | 0.3% | 7.1% | ||
| Q3 25 | -0.3% | -14.8% | ||
| Q2 25 | 5.4% | -18.5% | ||
| Q1 25 | 14.6% | -13.3% | ||
| Q4 24 | 23.7% | -11.3% | ||
| Q3 24 | 12.3% | -7.2% | ||
| Q2 24 | 8.1% | -9.1% | ||
| Q1 24 | 28.9% | -18.4% |
每股收益（稀释后）AXONNTRA
| Q4 25 | $0.02 | $0.36 | ||
| Q3 25 | $-0.03 | $-0.64 | ||
| Q2 25 | $0.44 | $-0.74 | ||
| Q1 25 | $1.08 | $-0.50 | ||
| Q4 24 | $1.68 | $-0.41 | ||
| Q3 24 | $0.86 | $-0.26 | ||
| Q2 24 | $0.53 | $-0.30 | ||
| Q1 24 | $1.73 | $-0.56 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | — |
| 总债务越低越好 | $1.8B | — |
| 股东权益账面价值 | $3.2B | $1.7B |
| 总资产 | $7.0B | $2.4B |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资AXONNTRA
| Q4 25 | $1.7B | — | ||
| Q3 25 | $2.4B | $1.0M | ||
| Q2 25 | $2.1B | $16.0M | ||
| Q1 25 | $2.2B | $17.8M | ||
| Q4 24 | $788.1M | $22.7M | ||
| Q3 24 | $1.0B | $29.5M | ||
| Q2 24 | $968.9M | $90.3M | ||
| Q1 24 | $964.1M | $69.1M |
总债务AXONNTRA
| Q4 25 | $1.8B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $680.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AXONNTRA
| Q4 25 | $3.2B | $1.7B | ||
| Q3 25 | $3.0B | $1.3B | ||
| Q2 25 | $2.7B | $1.2B | ||
| Q1 25 | $2.6B | $1.2B | ||
| Q4 24 | $2.3B | $1.2B | ||
| Q3 24 | $2.1B | $878.5M | ||
| Q2 24 | $1.9B | $836.5M | ||
| Q1 24 | $1.8B | $794.1M |
总资产AXONNTRA
| Q4 25 | $7.0B | $2.4B | ||
| Q3 25 | $6.7B | $1.8B | ||
| Q2 25 | $6.2B | $1.8B | ||
| Q1 25 | $6.1B | $1.7B | ||
| Q4 24 | $4.5B | $1.7B | ||
| Q3 24 | $4.0B | $1.6B | ||
| Q2 24 | $3.7B | $1.5B | ||
| Q1 24 | $3.6B | $1.5B |
负债/权益比AXONNTRA
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.66× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.79× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $217.2M | $73.9M |
| 自由现金流经营现金流 - 资本支出 | $155.4M | $37.8M |
| 自由现金流率自由现金流/营收 | 19.5% | 5.7% |
| 资本支出强度资本支出/营收 | 7.8% | 5.4% |
| 现金转化率经营现金流/净利润 | 79.14× | 1.56× |
| 过去12个月自由现金流最近4个季度 | $75.1M | $109.1M |
8季度趋势，按日历期对齐
经营现金流AXONNTRA
| Q4 25 | $217.2M | $73.9M | ||
| Q3 25 | $60.0M | $59.4M | ||
| Q2 25 | $-91.7M | $37.6M | ||
| Q1 25 | $25.8M | $44.5M | ||
| Q4 24 | $250.2M | $52.9M | ||
| Q3 24 | $91.3M | $51.8M | ||
| Q2 24 | $82.8M | $4.0M | ||
| Q1 24 | $-15.9M | $27.0M |
自由现金流AXONNTRA
| Q4 25 | $155.4M | $37.8M | ||
| Q3 25 | $33.4M | $37.0M | ||
| Q2 25 | $-114.7M | $11.7M | ||
| Q1 25 | $932.0K | $22.6M | ||
| Q4 24 | $225.4M | $34.8M | ||
| Q3 24 | $64.8M | $35.5M | ||
| Q2 24 | $71.4M | $-7.7M | ||
| Q1 24 | $-32.1M | $6.7M |
自由现金流率AXONNTRA
| Q4 25 | 19.5% | 5.7% | ||
| Q3 25 | 4.7% | 6.2% | ||
| Q2 25 | -17.2% | 2.1% | ||
| Q1 25 | 0.2% | 4.5% | ||
| Q4 24 | 39.3% | 7.3% | ||
| Q3 24 | 11.9% | 8.1% | ||
| Q2 24 | 14.2% | -1.9% | ||
| Q1 24 | -7.0% | 1.8% |
资本支出强度AXONNTRA
| Q4 25 | 7.8% | 5.4% | ||
| Q3 25 | 3.7% | 3.8% | ||
| Q2 25 | 3.4% | 4.7% | ||
| Q1 25 | 4.1% | 4.3% | ||
| Q4 24 | 4.3% | 3.8% | ||
| Q3 24 | 4.9% | 3.7% | ||
| Q2 24 | 2.2% | 2.8% | ||
| Q1 24 | 3.5% | 5.5% |
现金转化率AXONNTRA
| Q4 25 | 79.14× | 1.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | -2.54× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 1.84× | — | ||
| Q3 24 | 1.36× | — | ||
| Q2 24 | 2.03× | — | ||
| Q1 24 | -0.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXON
| Software And Sensors Segment | $342.5M | 43% |
| TASER Devices Professional | $264.2M | 33% |
| Personal Sensors | $109.1M | 14% |
| Platform Solutions | $80.9M | 10% |
NTRA
暂无分部数据
